ストックスクリーナーアプリを入手
2.0401
3.02%
0.0551
前日終値:
$1.985
開ける：
$2.01
24時間の取引高:
1.91M
Relative Volume:
0.53
時価総額：
$280.26M
収益：
-
当期純損益:
$-56.85M
株価収益率:
-1.3086
EPS:
-1.559
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+30.25%
1か月 パフォーマンス:
+80.97%
6か月 パフォーマンス:
+5.41%
1年 パフォーマンス:
-4.44%
1日の値動き範囲:
$1.955
$2.115
1週間の範囲:
$1.42
$2.115
52週間の値動き範囲:
$0.825
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
GUTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
2.045 | 271.35M | 0 | -56.85M | 0 | -1.559 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.44 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.54 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.48 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
898.10 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.09 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-15 | 開始されました | H.C. Wainwright | Buy |
| 2025-08-28 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-02-28 | 開始されました | Evercore ISI | Outperform |
| 2024-02-27 | 開始されました | BofA Securities | Buy |
| 2024-02-27 | 開始されました | Morgan Stanley | Overweight |
Fractyl Health Inc (GUTS) 最新ニュース
Fractyl Health says procedure can maintain weight loss after stopping GLP-1 - MSN
Fractyl Health's (GUTS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Promising Data and Future Prospects Lead to Buy Rating for Fractyl Health, Inc. - TipRanks
Fractyl Health stock maintains Buy rating at Canaccord on positive weight data - Investing.com UK
Breakout Zone: Why Fractyl Health Inc. stock is trending among retail tradersMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - BỘ NỘI VỤ
Fractyl procedure sustains weight loss after GLP-1s - BioWorld MedTech
Biotech says one-time procedure helps patients keep weight off post-GLP-1 - The Business Journals
What's Going On With Fractyl Health Stock Tuesday?Fractyl Health (NASDAQ:GUTS) - Benzinga
Fractyl Health, Inc.: Promising Outlook with Revita DMR’s Long-term Efficacy and Market Potential - TipRanks
Fractyl Health announces 6-month results from REVEAL-1 Cohort - TipRanks
Fractyl Health Says Revita Procedure Maintains Stable Weight After GLP-1 Discontinuation - marketscreener.com
Revita treatment shows stable weight in patients after GLP-1 discontinuation - Investing.com India
Fractyl Health Announces Positive REVEAL-1 Study Results - TipRanks
Fractyl Health Reports Positive 6-Month REVEAL-1 Results - TradingView
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure - The Manila Times
Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained ... - Enidnews.com
Fractyl Health (Nasdaq: GUTS) posts 1.5% mean weight change 6 months post-Revita - Stock Titan
Will Fractyl Health Inc. stock maintain growth storyJuly 2025 Market Mood & Momentum Based Trading Ideas - Newser
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Fractyl Health (Nasdaq: GUTS) to join fireside chat at 8th Annual Evercore Healthcare Conference - Stock Titan
Rate Cut: What margin trends mean for Fractyl Health Inc. stockEarnings Overview Report & AI Enhanced Execution Alerts - moha.gov.vn
Risk On: What margin trends mean for Fractyl Health Inc. stockQuarterly Portfolio Review & AI Forecasted Stock Moves - moha.gov.vn
Pharma News: Is Fractyl Health Inc. stock in correction or buying zone2025 Fundamental Recap & Trade Opportunity Analysis - BỘ NỘI VỤ
Canaccord Genuity raises Fractyl Health stock price target on positive data By Investing.com - Investing.com Nigeria
Canaccord Genuity raises Fractyl Health stock price target on positive data - Investing.com Canada
Fractyl Health price target raised to $8 from $6 at Canaccord - TipRanks
Will Fractyl Health Inc. stock sustain high P E ratiosMarket Rally & Safe Entry Trade Reports - newser.com
How Fractyl Health Inc. stock benefits from strong dollar2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Why Fractyl Health Inc. stock attracts global investorsEarnings Summary Report & AI Driven Price Predictions - newser.com
What Wall Street predicts for Fractyl Health Inc. stock price2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
How to integrate Fractyl Health Inc. into portfolio analysis tools2025 Technical Overview & Daily Stock Trend Watchlist - newser.com
Is Fractyl Health Inc. stock ready for a breakoutTrade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Is Fractyl Health Poised for a Bounce? - StocksToTrade
Fractyl Health, Inc. (GUTS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Fractyl Health Inc. stock maintain dividend yield2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Volatility clustering patterns for Fractyl Health Inc.Weekly Trend Summary & Free Technical Confirmation Trade Alerts - newser.com
Fractyl Health Inc. stock retracement – recovery analysisJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com
Fractyl Health Bets On Post-GLP-1 Weight Loss Fix - Finimize
Signal strength of Fractyl Health Inc. stock in tech scannersWeekly Profit Recap & Daily Volume Surge Signals - newser.com
Is Fractyl Health Inc a good long term investmentEarnings Call Summaries & Big Gains Small Capital - earlytimes.in
Can Fractyl Health Inc. stock outperform in 2025 bull market2025 Fundamental Recap & Intraday High Probability Setup Alerts - Fundação Cultural do Pará
Fractyl Health Inc (GUTS) 財務データ
収益
当期純利益
現金流量
EPS
Fractyl Health Inc (GUTS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Barnes Kelly Ann | Director |
Mar 14 '25 |
Buy |
1.30 |
31,000 |
40,210 |
31,000 |
| SCHULMAN AMY W | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| BRADLEY WILLIAM | Director |
Mar 13 '25 |
Buy |
1.26 |
16,129 |
20,358 |
16,129 |
| Conaway Samuel | Director |
Mar 13 '25 |
Buy |
1.17 |
8,550 |
9,964 |
8,550 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Option Exercise |
1.70 |
90,972 |
154,652 |
582,301 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Option Exercise |
1.70 |
20,948 |
35,612 |
512,277 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 31 '25 |
Sale |
1.82 |
90,972 |
165,205 |
491,329 |
| Rajagopalan Harith | Chief Executive Officer |
Jan 30 '25 |
Sale |
1.95 |
20,948 |
40,798 |
491,329 |
| Caplan Jay David | President, Chief Product Off. |
Jan 31 '25 |
Option Exercise |
1.70 |
22,346 |
37,988 |
175,890 |
| Caplan Jay David | President, Chief Product Off. |
Jan 30 '25 |
Option Exercise |
1.70 |
21,472 |
36,502 |
175,016 |
0.83%
0.99%
大文字化:
|
ボリューム (24 時間):